Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia.
Ontology highlight
ABSTRACT: Insulin detemir is commonly used in obese patients with diabetes mellitus as it is considered hepatoselective and causes less weight gain. We describe a relative lack of effectiveness of detemir in patients with significant NAFLD and hypertriglyceridemia, compared to isophane insulin. This may affect how such patients are managed with insulin.
SUBMITTER: Whyte M
PROVIDER: S-EPMC4706392 | biostudies-other | 2016 Jan
REPOSITORIES: biostudies-other
ACCESS DATA